Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$120,000.00

Donor Lymphocyte Infusion for the Treatment of Disease Relapse after Umbilical Cord Blood Transplantation

FY 2012-13

Summary
Patients with blood cancers often require a bone marrow transplant from a healthy donor to provide them with a chance of cure from their disease. This donor can be a related or unrelated healthy volunteer who matches the patient. Although many patients will be cured, there is always a risk of relapse of the cancer after transplant. In this circumstance, patients have the opportunity to undergo a transfusion of specific white blood cells from the healthy donor in order to try and kill the relapsed cancer cells. This process is called donor lymphocyte infusion and provides a hope for cure in patients who have cancer recurrence after transplant. In certain cases, if there is no available donor for a patient, doctors will use umbilical cord blood that has been frozen and stored from healthy volunteers. In this setting, the patient still has the potential of cure from their disease, but does not have the option of donor lymphocyte infusion at the time of relapse. We are seeking to address the use of donor lymphocyte infusion from a healthy adult donor who matches the cord blood unit in order to treat relapse in this special group of patients. This study will analyze the safety and efficacy of this strategy with the hopes that this will cure patients who otherwise have no option when they relapse after umbilical cord blood transplant.
Program
CIHR Fellowship
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
285033
Name
Kekre Natasha
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
Donor Lymphocyte Infusion for the Treatment of Disease Relapse after Umbilical Cord Blood Transplantation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Disease Relapse; Donor Lymphocyte Infusion; Hematologic Malignancies; Hematopoietic Stem Cell Transplant; Umbilical Cord Blood
Abstract
Patients with blood cancers often require a bone marrow transplant from a healthy donor to provide them with a chance of cure from their disease. This donor can be a related or unrelated healthy volunteer who matches the patient. Although many patients will be cured, there is always a risk of relapse of the cancer after transplant. In this circumstance, patients have the opportunity to undergo a transfusion of specific white blood cells from the healthy donor in order to try and kill the relapsed cancer cells. This process is called donor lymphocyte infusion and provides a hope for cure in patients who have cancer recurrence after transplant. In certain cases, if there is no available donor for a patient, doctors will use umbilical cord blood that has been frozen and stored from healthy volunteers. In this setting, the patient still has the potential of cure from their disease, but does not have the option of donor lymphocyte infusion at the time of relapse. We are seeking to address the use of donor lymphocyte infusion from a healthy adult donor who matches the cord blood unit in order to treat relapse in this special group of patients. This study will analyze the safety and efficacy of this strategy with the hopes that this will cure patients who otherwise have no option when they relapse after umbilical cord blood transplant.
Competitiondate
201302
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kekre, Natasha
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~
Direct Payment - $120,000 Grant (2012-13) | Canada Spends